NYSE:DPLO (USA) Also Trade In: Germany
Warning! GuruFocus has detected with DPLO. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for DPLO (Diplomat Pharmacy Inc) from 2014 to Apr 21 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Diplomat Pharmacy stock (DPLO) PE ratio as of Apr 21 2021 is 0. More Details
Diplomat Pharmacy PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Diplomat Pharmacy PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
4100 South Saginaw Street, Flint, MI, USA, 48507
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.